Do infants increase the risk of re-emergent infection in households after mass drug administration for trachoma?

Research output: Contribution to journalArticle

Abstract

Purpose. Mass treatment with azithromycin for trachoma endemic communities typically excludes infants under age 6 months, whose parents are provided with tubes of tetracycline to administer daily over 4 to 6 weeks. The authors sought to determine whether infants aged

Original languageEnglish (US)
Pages (from-to)6040-6042
Number of pages3
JournalInvestigative Ophthalmology and Visual Science
Volume52
Issue number8
DOIs
StatePublished - Jul 2011

Fingerprint

Trachoma
Azithromycin
Infection
Tetracycline
Pharmaceutical Preparations
Parents
Therapeutics

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience
  • Medicine(all)

Cite this

@article{54a5e1b29638422fbf20109d487f3872,
title = "Do infants increase the risk of re-emergent infection in households after mass drug administration for trachoma?",
abstract = "Purpose. Mass treatment with azithromycin for trachoma endemic communities typically excludes infants under age 6 months, whose parents are provided with tubes of tetracycline to administer daily over 4 to 6 weeks. The authors sought to determine whether infants aged",
author = "West, {Sheila K} and Dianne Stare and Harran Mkocha and Beatriz Munoz and Gaydos, {Charlotte A} and Quinn, {Thomas C}",
year = "2011",
month = "7",
doi = "10.1167/iovs.11-7372",
language = "English (US)",
volume = "52",
pages = "6040--6042",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "8",

}

TY - JOUR

T1 - Do infants increase the risk of re-emergent infection in households after mass drug administration for trachoma?

AU - West, Sheila K

AU - Stare, Dianne

AU - Mkocha, Harran

AU - Munoz, Beatriz

AU - Gaydos, Charlotte A

AU - Quinn, Thomas C

PY - 2011/7

Y1 - 2011/7

N2 - Purpose. Mass treatment with azithromycin for trachoma endemic communities typically excludes infants under age 6 months, whose parents are provided with tubes of tetracycline to administer daily over 4 to 6 weeks. The authors sought to determine whether infants aged

AB - Purpose. Mass treatment with azithromycin for trachoma endemic communities typically excludes infants under age 6 months, whose parents are provided with tubes of tetracycline to administer daily over 4 to 6 weeks. The authors sought to determine whether infants aged

UR - http://www.scopus.com/inward/record.url?scp=80053302976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053302976&partnerID=8YFLogxK

U2 - 10.1167/iovs.11-7372

DO - 10.1167/iovs.11-7372

M3 - Article

C2 - 21680866

AN - SCOPUS:80053302976

VL - 52

SP - 6040

EP - 6042

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 8

ER -